Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study
- PMID: 38021373
- PMCID: PMC10659995
- DOI: 10.1016/j.eclinm.2023.102286
Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study
Abstract
Background: Guidelines to treat iron deficiency recommend daily provision of oral iron, but this may decrease fractional iron absorption and increase side effects. Our objective was to compare consecutive-day versus alternate-day iron supplementation.
Methods: In a double-masked, randomized, placebo-controlled trial, young Swiss women (n = 150; serum ferritin ≤30 μg/L) were assigned to: daily 100 mg iron for 90 d, followed by daily placebo for another 90 d (consecutive-day group) or the same daily dose of iron and placebo on alternate days for 180 d (alternate-day group). The study period was 24/11/2021-10/8/2022. Co-primary outcomes, at equal total iron doses, were serum ferritin and gastrointestinal side effects; secondary outcomes were iron deficiency and serum hepcidin. Compliance and side effects were recorded daily using a mobile application. Data were analysed using mixed models and longitudinal prevalence ratios (LPR). The trial was registered at ClinicalTrials.gov (NCT05105438).
Findings: 75 women were assigned to each group and included in the intention-to-treat analysis. Capsule adherence and side effect reporting was >97% in both groups. At equal total iron doses, comparing consecutive-day and alternate-day groups, median serum ferritin was 43.8 μg/L (31.7-58.2) versus 44.8 μg/L (33.8-53.6) (P = 0.98), the LPR for gastrointestinal side effects on days of iron intake was 1.56 (95% CI: 1.38, 1.77; P < 0.0001), and median serum hepcidin was 3.0 nM (IQR 2.0-5.0) versus 1.9 nM (1.4-2.9) (P < 0.0001). Iron deficiency prevalence after 3 months was 5.5% versus 4.3% (P = 0.74) and after 6 months was 11.4% and 3.0% (P = 0.049).
Interpretation: At equal total iron doses, compared to consecutive day dosing of iron, alternate day dosing did not result in higher serum ferritin but reduced iron deficiency at 6 months and triggered fewer gastrointestinal side effects.
Funding: Swiss National Science Foundation, Bern, Switzerland.
Keywords: Alternate day; Daily; Deficiency; Gastrointestinal side effects; Hepcidin; Iron; Supplementation.
Crown Copyright © 2023 Published by Elsevier Ltd.
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10659995/bin/gr1.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10659995/bin/gr2.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10659995/bin/gr3.gif)
Similar articles
-
Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials.Lancet Haematol. 2017 Nov;4(11):e524-e533. doi: 10.1016/S2352-3026(17)30182-5. Epub 2017 Oct 9. Lancet Haematol. 2017. PMID: 29032957 Clinical Trial.
-
Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women.Haematologica. 2020 May;105(5):1232-1239. doi: 10.3324/haematol.2019.220830. Epub 2019 Aug 14. Haematologica. 2020. PMID: 31413088 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Oral iron supplementation in iron-deficient women: How much and how often?Mol Aspects Med. 2020 Oct;75:100865. doi: 10.1016/j.mam.2020.100865. Epub 2020 Jul 7. Mol Aspects Med. 2020. PMID: 32650997 Review.
-
Daily versus alternate day oral iron therapy in iron deficiency anemia: a systematic review.Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2701-2714. doi: 10.1007/s00210-023-02817-7. Epub 2023 Nov 18. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37979057 Review.
Cited by
-
Is It Time to Alter the Standard of Care for Iron Deficiency/Iron Deficiency Anemia in Reproductive-Age Women?Biomedicines. 2024 Jan 25;12(2):278. doi: 10.3390/biomedicines12020278. Biomedicines. 2024. PMID: 38397880 Free PMC article. Review.
References
Associated data
LinkOut - more resources
Full Text Sources